BioFlyte Raises $5.4M in Series B Financing

BioFlyte

BioFlyte, an Albuquerque, NM-based biothreat detection firm with a new class of fieldable biological threat collection, detection, and identification solutions, raised $5.4M in funding.

The round was led by Scout Ventures and Cottonwood Technology Fund with additional funding from New Mexico Vintage Fund. Brad Harrison, Managing Partner of Scout Ventures, who recently joined the company’s Board of Directors.

The company intends to use the funds to continue scaling its manufacturing and sales operations.

Led by Todd Sickles, CEO, BioFlyte provides BioTOF™ z200, a biothreat surveillance solution for critical infrastructure protection and mail screening. The z200 provides test results in less than five minutes and operates continuously and autonomously in critical infrastructure environments such as airports, arenas, entertainment venues, and commercial and government buildings. The technology is also being used for screening within mail processing environments.

The system consists of a wall mount sensor capable of autonomous detection and identification of airborne toxins in real-time. It incorporates matrix-assisted laser desorption and ionization (MALDI) mass spectrometry to acquire a mass spectrum from each collected aerosol sample. The BioTOF sensor offers high sensitivity at 100 threat particles per liter of ambient air. By incorporating ML/AI, the instrument continuously detects, characterizes, and stores new species in its libraries for future reference, thus giving it the ability to accurately and quickly identify an unprecedented range of toxins, viruses, and bacteria such as anthrax, ricin and fentanyl.

FinSMEs

10/08/2023